更新
3月17日 - ** 医疗技术公司CONMED CNMD.N股价下跌1.7%，报36.78美元
** Piper Sandler 将 CNMD 的评级从 "增持 "下调至 "中性"，理由是缺乏短期催化剂。
** 表示对 AirSeal 业绩和执行失误的持续担忧已拖累该股近两年时间
** 将目标价下调至 39 美元，这仍意味着 该股较上次收盘价有 4.3% 的上涨空间
** 覆盖CNMD的所有六家券商均将其股票评级为"持有"； PT中值为43美元--LSEG数据
** 包括本交易日的走势在内，CNMD今年累计下跌约9.6%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.